Actuate Therapeutics Inc - ROE
ACTU
Price:
$2.07
Market Cap:
$49.53M
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Industry
Biotechnology
IPO Date
2024-08-13
Stock Exchange
NASDAQ
Ticker
ACTU
PE Ratio
[-2.13]
ROE
[-430.93%]
Current Ratio
[1.80]
Dividend Yield
[0%]
Enterprise Value
[41.80M]
Dividend History
The ROE as of June 2026 (TTM) for Actuate Therapeutics Inc (ACTU) is -430.93%
According to Actuate Therapeutics Inc’s latest financial reports and current stock price. The company's current ROE is -430.93%. This represents a change of 5.39% compared to the average of -7.84% of the last 4 quarters.
Actuate Therapeutics Inc (ACTU) Historical ROE (quarterly & annually)
How has ACTU ROE performed in the past?
The mean historical ROE of Actuate Therapeutics Inc over the last ten years is -6645.16%. The current -430.93% ROE has changed -93.52% with respect to the historical average. Over the past ten years (40 quarters), ACTU's ROE was at its highest in in the June 2025 quarter at 224.19%. The ROE was at its lowest in in the December 2024 quarter at -6187.10%.
Average
-6645.16%
Median
-208.21%
Minimum
-26189.05%
Maximum
24.84%
Actuate Therapeutics Inc (ACTU) ROE by Quarter and Year
Discovering the peaks and valleys of Actuate Therapeutics Inc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 24.84%
Minimum Annual Increase = -105542.08%
Minimum Annual ROE = -26189.05%
| Year | ROE | Change |
|---|---|---|
| 2025 | -280.51% | -98.93% |
| 2024 | -26189.05% | -105542.08% |
| 2023 | 24.84% | -118.27% |
Actuate Therapeutics Inc (ACTU) Average ROE
How has ACTU ROE performed in the past?
The current ROE of Actuate Therapeutics Inc (ACTU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8814.91%
5-year avg
-6645.16%
10-year avg
-6645.16%
Actuate Therapeutics Inc (ACTU) ROE vs. Peers
How is ACTU’s ROE compared to its peers?
Actuate Therapeutics Inc’s ROE is greater than Seres Therapeutics, Inc. (-127.30%), less than Spero Therapeutics, Inc. (35.58%), greater than VistaGen Therapeutics, Inc. (-133.02%), greater than Applied Therapeutics, Inc. (-65.63%), greater than Elicio Therapeutics, Inc. (-2748.16%), greater than Nkarta, Inc. (-30.90%), less than Vor Biopharma Inc. (87.31%), greater than Alector, Inc. (-295.17%), greater than Molecular Partners AG (-66.19%), greater than PepGen Inc. (-59.89%),
| Company | ROE | Market cap |
|---|---|---|
| -127.30% | $64.01M | |
| 35.58% | $132.02M | |
| -133.02% | $21.96M | |
| -65.63% | $14.86M | |
| -2748.16% | $73.48M | |
| -30.90% | $204.62M | |
| 87.31% | $99.31M | |
| -295.17% | $194.29M | |
| -66.19% | $143.29M | |
| -59.89% | $123.81M |
Build a custom stock screener for Actuate Therapeutics Inc (ACTU) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actuate Therapeutics Inc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Actuate Therapeutics Inc (ACTU) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Actuate Therapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Actuate Therapeutics Inc's ROE?
How is the ROE calculated for Actuate Therapeutics Inc (ACTU)?
What is the highest ROE for Actuate Therapeutics Inc (ACTU)?
What is the 3-year average ROE for Actuate Therapeutics Inc (ACTU)?
What is the 5-year average ROE for Actuate Therapeutics Inc (ACTU)?
How does the current ROE for Actuate Therapeutics Inc (ACTU) compare to its historical average?